the vaccine – Page 92 – Communicable Diseases Research

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines

COVID-19 백신의 유효성 및 안전성에 대한 포괄적인 분석

Meta-Analysis

Published on 2021-09-012022-09-11
Journal: Molecular therapy : the journal of the American So [Category] MERS, SARS, 변종, 임상, 진단,

The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience

청소년 및 암에 걸린 젊은 성인을 위한 BNT162b2 mRNA COVID-19 백신: 단일 중심 경험

Comparative Study

Published on 2021-09-012022-09-12
Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, 신약개발, 진단,

[키워드] Administered administration Affect antibody AYA BNT162b2 mRNA Cancer Care COVID COVID-19 COVID-19 infection COVID-19 vaccine Critical determine Efficacy IgG IgG antibody Immunoglobulin include infections injection Local mandatory median Mild neutralisation neutralisation test oncology one patient Paediatric oncology paediatric patient Pain Patient patients positive COVID-19 positive serology pre-vaccination progression reactivity Retrospective analysis S1 domain safety profile Seroconversion serology serology testing Side-effect solid tumour Symptom systemic symptom tested the spike protein the vaccine Treatment Tumours vaccination Vaccine vaccine injection was tested were given
[DOI] 10.1016/j.ejca.2021.06.002 PMC 바로가기 [Article Type] Comparative Study

Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine

Observational Study

Published on 2021-09-012022-10-05
Journal: Ultrasound in obstetrics & gynecology : the offici [Category] 임상,

[키워드] acute respiratory syndrome Administered Admission age arthralgia asked bleeding Blood BNT162b2 mRNA BNT162b2 vaccine calculated case-control study comparable complications control group coronavirus coronavirus disease COVID-19 COVID-19 vaccine death demographics determine dose doses effective evaluate fetal Fever first dose gestation Gynecology headache humoral immune response IgG Immunoglobulin in both group Infection information intensive care interquartile range less Local local pain median medication membrane Neonatal no significant difference Obstetric obstetric outcome offered outcome outcomes participant Patient Pfizer/BioNTech positive Pregnancy pregnant population pregnant women Preterm birth questionnaire Rash reactogenicity recruited Respiratory Support returned rupture SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 IgG second dose second vaccination serology serum serum sample severe fatigue Side effect significantly significantly lower significantly more Society study group study period the study group the vaccine two groups two-dose regimen Ultrasound uterine vaccination Vaccine vaccine dose women
[DOI] 10.1002/uog.23729 PMC 바로가기 [Article Type] Observational Study

Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study

Research Paper

Published on 2021-09-012022-10-29
Journal: The Lancet Regional Health - Americas [Category] COVID-19,

[키워드] 95% CI accounted acute respiratory syndrome adjusted administration affected age analyses Analysis average Brazil Case-control case-control study Complete CoronaVac coronavirus coronavirus disease COVID-19 dose Effectiveness eligible Epidemic finding first dose funding Gamma genotyped HCW HCWs healthcare worker Inactivated vaccine individual information Intervention IQR maintain Older P.1 variant performed positive Primary outcome receiving reduction reported RT-PCR RT-PCR testing RT-PCR tests SARS-CoV-2 second dose Secretary selected Spread study population symptomatic SARS-CoV-2 infection test-negative study the vaccine Transmission vaccinated individual vaccination Vaccine vaccine dose variant widespread
[DOI] 10.1016/j.lana.2021.100025 PMC 바로가기 [Article Type] Research Paper

BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers

BNT162b2 COVID-19 백신과 체액성 면역 반응 및 역학의 상관 관계: 의료 종사자를 대상으로 한 전향적, 단일 센터, 종단 코호트 연구

Observational Study

Published on 2021-09-012022-09-12
Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 진단,

[키워드] 95% CI abrogated administration age analyses anti-SARS-CoV-2 IgG antibody antibody concentration antibody kinetics Antibody Response Antibody test Autoimmune disease baseline BNT162b2 BNT162b2 vaccine breakthrough infections center Comorbidities Comorbidity concurrent correlation COVID-19 vaccine diabete disease domain dose elicited eligible Endpoint first dose Follow-up greater health-care high correlation highlighting humoral immune response hypertension IgA IgG IgG antibody IgG response IgM Immunosuppressed Immunosuppression individual individuals induce infection with COVID-19 initiated intramuscular linear mixed model linear regression analyses Logistic longitudinal cohort study Male sex Ministry of Health neutralisation neutralisation titre neutralising antibody neutralising antibody response neutralising antibody titres neutralising assay Older Older age over participant Participants Pfizer-BioNTech Population positive positive SARS-CoV-2 PCR receiving reduced regression analysis responses robust Scatter plot second dose second vaccination serological serology test serum sample significantly lower study population susceptible tested the receptor-binding domain the vaccine titre vaccination Vaccine vaccine dose were excluded were used
[DOI] 10.1016/S2213-2600(21)00220-4 PMC 바로가기 [Article Type] Observational Study

Thrombotic events and COVID-19 vaccines

State of the Art

Published on 2021-09-012022-10-29
Journal: The international journal of tuberculosis and lung [Category] COVID-19, SARS,

An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest

우려 및 관심의 변이를 포함하는 SARS-CoV-2에 대항하는 백신의 효과적인 개발을 위한 잠재적인 다중 에피토프 구성을 설계하기 위한 심층 실리코 및 면역정보학 접근 방식

Article

Published on 2021-09-012022-09-11
Journal: Computers in biology and medicine [Category] SARS, 변종,

[키워드] ACE2 receptor acute respiratory syndrome acute respiratory syndrome coronavirus adaptive Antibody titer antigenicity approach B cell B cell epitope B-cell epitope B.1.1.7 B.1.351 B.1.427 B.1.429 B.1.526 B.1.617.1 B.1.617.2 binding Cell cells coronavirus COVID-19 effective elevated epitope Health immune response Immunity immunoinformatics in silico in vitro linker linkers MEV Multi-epitope vaccine NK cells nucleotide nucleotide sequence ORF1 ORF10 ORF1ab ORF3a ORF6 ORF7a ORF7b ORF8 outbreak P.1 P.2 Pathogens Physicochemical properties polyprotein present Prevent preventive measure receptor S protein SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 proteins selected severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 T cell T cell epitope T-cell the vaccine TLR2 TLR4 Toll-like receptor Toll-like receptors turn utility Vaccine vaccine construct variants variants of concern variants of interest variants of SARS-CoV-2 viral pathogen were used
[DOI] 10.1016/j.compbiomed.2021.104703 PMC 바로가기 [Article Type] Article

Emergence of highly infectious SARS-CoV-2 variants in Bangladesh: the need for systematic genetic surveillance as a public health strategy

Letter to the Editor

Published on 2021-09-012022-10-28
Journal: Tropical Medicine and Health [Category] COVID-19,

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

초기 SARS-CoV-2 백신 접종 반응은 BNT162b2에 대한 추가 반응을 예측할 수 있지만 AZD1222에 대해서는 예측할 수 없습니다

Article

Published on 2021-09-012022-09-12
Journal: International Journal of Infectious Diseases [Category] SARS, 진단,

Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk

Research

Published on 2021-08-312022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS, SARS,

[키워드] Adverse reaction age Algorithm allergic allergic disease allergic reaction Allergic reactions allergies allergy Anaphylactic reaction anaphylactic reactions applied BNT162b2 BNT162b2 vaccine Can center cohort study comparable condition COVID 19 COVID-19 COVID-19 vaccine defined dose exposure finding first dose General population had no high risk immunization immunized Importance include individual late reaction measure medical supervision Mild objective of BNT162b2 Other participant Patient patients Pfizer-BioNTech physician Point prospective cohort study questionnaire reaction receive receiving Relevance required responses Result risk risk factor second dose setting study period the mean the vaccine to define vaccination Vaccine was used women
[DOI] 10.1001/jamanetworkopen.2021.22255 PMC 바로가기 [Article Type] Research